In August 2005, Cellomics Inc was acquired by Fisher Scientific International Inc for $49 Million. Cellomics Inc, formerly known as BioDx Inc, is developing and commercializing products in the field of cellomics to extend the advances in genomics and proteomics. The firm is engaging in the development of an integrated product platform, including high content screening products to measure the physical position and activity over time of cells and cellular components. The company integrates fluorescent reagents, kits, cell lines, multiparametric assays, informatics, cell analysis instrumentation, and cellular bioinformatics tools to achieve an applicable platform for users in the pharmaceutical industry.